MCRB 8-K 2026-11-04

Seres Therapeutics, Inc. (MCRB) 8-K dated 2026-11-04 — accession 0001193125-26-446185.

Seres Therapeutics, Inc. (MCRB) is a biotechnology company listed on US.

Seres Therapeutics, Inc. filed a 8-K on 2026-11-04. Accession 0001193125-26-446185.

This 8-K covers: Results of operations (Item 2.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported MCRB revenue for 2025-12-31 was $789.0K. Net income was $5.7M. MCRB currently screens at market cap $109.8M.

Not investment advice. The MCRB SEC hub lists recent forms. The stock page is the research view.